Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2017 Sep 2;13(1):77–89. doi: 10.1007/s11481-017-9762-5

Table 2.

Difference Between Pain Measures* in HIV+ Participants and SN controls (mean ± S.E.)

Average T-scores SN Control (n=31) HIV+
Participants
(n=35)
P-value from
Unpaired T-test
Pain Intensity 40.8 ± 1.3 46.7 ± 1.5 0.005
Pain Interference 48.6 ± 1.5 54.2 ± 1.3 0.008
Pain Behavior 49.0 ± 1.7 53.6 ± 1.4 0.04
*

Pain Measures: T-score ≥ 60 is 1 SD worst than US general population; T-score ≤ 40 is 1 SD better than US general population. T-score generated is based on US population July 2006–March 2007; Sept 2007–Mar 2008 (n = 21,133 + 967; mean age 48.2; 52% female; 82% white, 9% black, 8% multiracial, 1% other; 3% < HS, 16% HS, 39% some college, 24% college, 19% post-baccalaureate)